Evaluating the effect of PD-1 inhibitors on left ventricular function in lung cancer with noninvasive myocardial work

BACKGROUND: The treatment of advanced lung cancer has been revolutionized by immune checkpoint inhibitors (ICIs) in recent years, largely driven by programmed cell death-1 (PD-1) inhibitors. However, patients with lung cancer who are treated with PD-1 inhibitors are prone to immune-related adverse e...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xia, Wang, Chujun, Kang, Ruirui, Zhao, Yu, Chen, Lili, Liu, Fengzhen, Wang, Xiaolin, Peng, Yulan, Zhang, Chunquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167462/
https://www.ncbi.nlm.nih.gov/pubmed/37179944
http://dx.doi.org/10.21037/qims-22-817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167462/
https://www.ncbi.nlm.nih.gov/pubmed/37179944
http://dx.doi.org/10.21037/qims-22-817

Ejemplares similares